I. Fu
Impact in
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
- Spectroscopy top 5%
- Analytical Chemistry and Chromatography
- Mass Spectrometry Techniques and Applications
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Eric Woolf (9 shared papers)B.K. Matuszewski (7 shared papers)Yang Xu (1 shared paper)Mark J. Rose (1 shared paper)Lihong Du (1 shared paper)Donald G. Musson (1 shared paper)M.L. Constanzer (1 shared paper)C.M. Chavez-Eng (1 shared paper)
- Journals
- Journal of Chromatography B (3 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)British Journal of Clinical Pharmacology (1 paper)Clinical Chemistry (1 paper)Chromatographia (1 paper)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
I. Fu
12 papers receiving 371 citations
Peers
Comparison fields: 5 of 75
- Analytical Chemistry 123
- Spectroscopy 166
- Pharmacology 105
- Food Science 89
- Toxicology 15
Countries citing papers authored by I. Fu
This map shows the geographic impact of I. Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Fu more than expected).
Fields of papers citing papers by I. Fu
This network shows the impact of papers produced by I. Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Fu. The network helps show where I. Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside I. Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 185 | |
| 2 | 1999 | 50 | |
| 3 | 2004 | 39 | |
| 4 | 2005 | 33 | |
| 5 | 2008 | 26 | |
| 6 | 2004 | 26 | |
| 7 | 2007 | 19 | |
| 8 | 1991 | 6 | |
| 9 | Abstract #3604: A phase I single-rising dose study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of an oral akt inhibitor in healthy male volunteers | 2009 | 4 |
| 10 | 2002 | 2 | |
| 11 | 1999 | 2 | |
| 12 | 1993 | 1 |
About I. Fu
I. Fu is a scholar working on Pharmacology, Molecular Biology, Spectroscopy, Analytical Chemistry and Infectious Diseases, having authored 12 papers that have together received 393 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Analytical Methods in Pharmaceuticals (3 papers), Analytical Chemistry and Chromatography (3 papers), Pharmacological Effects and Assays (2 papers), HIV/AIDS drug development and treatment (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Fatty Acid Research and Health (1 paper). The work is most often cited by research in Analytical Chemistry (123 citations), Spectroscopy (166 citations), Pharmacology (105 citations), Food Science (89 citations) and Toxicology (15 citations). I. Fu has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Eric Woolf, B.K. Matuszewski, Yang Xu, Mark J. Rose, Lihong Du, Donald G. Musson, M.L. Constanzer, C.M. Chavez-Eng, Larry D. Bowers and Patrick T. Vallano. Their work appears in journals such as Journal of Chromatography B, Journal of Pharmaceutical and Biomedical Analysis, British Journal of Clinical Pharmacology, Clinical Chemistry and Chromatographia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.